These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21392123)

  • 1. Health and doping in elite-level cycling.
    Lentillon-Kaestner V; Hagger MS; Hardcastle S
    Scand J Med Sci Sports; 2012 Oct; 22(5):596-606. PubMed ID: 21392123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping use among young elite cyclists: a qualitative psychosociological approach.
    Lentillon-Kaestner V; Carstairs C
    Scand J Med Sci Sports; 2010 Apr; 20(2):336-45. PubMed ID: 19486486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
    Outram SM; Stewart B
    Int J Drug Policy; 2015 Jul; 26(7):682-7. PubMed ID: 25666447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of doping use in high-level cycling: from team-organized doping to advances in the fight against doping.
    Lentillon-Kaestner V
    Scand J Med Sci Sports; 2013 Mar; 23(2):189-97. PubMed ID: 22092601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doing supplements to improve performance in club cycling: a life-course analysis.
    Stewart B; Outram S; Smith AC
    Scand J Med Sci Sports; 2013 Dec; 23(6):e361-72. PubMed ID: 23909650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplement and drug use and doping knowledge and attitudes in Italian young elite cyclists.
    Loraschi A; Galli N; Cosentino M
    Clin J Sport Med; 2014 May; 24(3):238-44. PubMed ID: 24184855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Korean national athletes' knowledge, practices, and attitudes of doping: a cross-sectional study.
    Kim T; Kim YH
    Subst Abuse Treat Prev Policy; 2017 Feb; 12(1):7. PubMed ID: 28196542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Athletes' knowledge and views on OTC medication.
    Mottram D; Chester N; Atkinson G; Goode D
    Int J Sports Med; 2008 Oct; 29(10):851-5. PubMed ID: 18401811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping and supplementation: the attitudes of talented young athletes.
    Bloodworth AJ; Petróczi A; Bailey R; Pearce G; McNamee MJ
    Scand J Med Sci Sports; 2012 Apr; 22(2):293-301. PubMed ID: 20973831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N; Wojek N
    Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting elite Scottish athletes' attitudes towards doping: examining the contribution of achievement goals and motivational climate.
    Allen J; Taylor J; Dimeo P; Dixon S; Robinson L
    J Sports Sci; 2015; 33(9):899-906. PubMed ID: 25537139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doping in sports: knowledge and attitudes among parents of Austrian junior athletes.
    Blank C; Leichtfried V; Schaiter R; Fürhapter C; Müller D; Schobersberger W
    Scand J Med Sci Sports; 2015 Feb; 25(1):116-24. PubMed ID: 24372621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.